Skip to content

Effectiveness of Thai traditional massage, Thai herbal compress versus oral drug therapy in treatment of osteoarthritis of knee: A randomized controlled trial

Effectiveness of Thai traditional massage, Thai herbal compress versus oral drug therapy in treatment of osteoarthritis of knee: A randomized controlled trial.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001238
Enrollment
Unknown
Registered
2011-03-21
Start date
2011-03-04
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

1:Thai Traditional Massage, three times a week for 3 weeks
2:Thai Herbal Compress, three times a week for 3 weeks
3:Ibuprofen (400 mg) 1 tablet, 3 times daily for 3 week

Sponsors

Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
25 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with unilateral or bilateral OA of the knee according to the criteria of the American College of Rheumatology for more than 3 months; 2. After discontinuation of usual medications for 7 days, the visual analog scale (VAS) score assessing pain during the most painful knee movement must be between 40-70; 3. Participants must be able to walk and give both verbal and written information regarding the study.

Exclusion criteria

Exclusion criteria: 1. Underlying inflammatory arthropathy, expectation of surgery in the near future, recent injury in the area affected by OA of the knee, intra-articular corticosteroid injections within the last 3 months, history of peptic ulceration and upper GI hemorrhage, coagulopathies, uncontrolled hypertension, congestive heart failure, diabetes, hyperkalemia, pregnancy, lactation and malignant tumors; 2. In patients randomized to recieve oral NSAIDs, the exclusion criteria also include hypersensitivity to NSAIDs, abnormal liver or kidney function tests, and major abnormal finding on complete blood count.

Design outcomes

Primary

MeasureTime frame
Visual analog scale (VAS) score;

Secondary

MeasureTime frame
Lequesne's functional index;

Contacts

Public ContactSupanimit Teekachunhatean M.D., Ph.D.
steekach@med.cmu.ac.th+66-53-945353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026